Protective Effects of Traditional Polyherbs on Cisplatin-Induced Acute Kidney Injury Cell Model by Inhibiting Oxidative Stress and MAPK Signaling Pathway.
VinayKumar DachuriPhil Hyun SongYoung-Woo KimSae Kwang KuChang-Hyun SongPublished in: Molecules (Basel, Switzerland) (2020)
Acute kidney injury (AKI) is a disease caused by sudden renal dysfunction, which is an important risk factor for chronic renal failure. However, there is no effective treatment for renal impairment. Although some traditional polyherbs are commercially available for renal diseases, their effectiveness has not been reported. Therefore, we examined the nephroprotective effects of polyherbs and their relevant mechanisms in a cisplatin-induced cell injury model. Rat NRK-52E and human HK-2 subjected to cisplatin-induced AKI were treated with four polyherbs, Injinhotang (IJ), Ucha-Shinki-Hwan (US), Yukmijihwang-tang (YJ), and UrofenTM (Uro) similar with Yondansagan-tang, for three days. All polyherbs showed strong free radical scavenging activities, and the treatments prevented cisplatin-induced cell death in both models, especially at 1.2 mg/mL. The protective effects involved antioxidant effects by reducing reactive oxygen species and increasing the activities of superoxide dismutase and catalase. The polyherbs also reduced the number of annexin V-positive apoptotic cells and the expression of cleaved caspase-3, along with inhibited expression of mitogen-activated protein kinase-related proteins. These findings provide evidence for promoting the development of herbal formulas as an alternative therapy for treating AKI.
Keyphrases
- acute kidney injury
- oxidative stress
- induced apoptosis
- cell death
- signaling pathway
- cardiac surgery
- cell cycle arrest
- poor prognosis
- reactive oxygen species
- pi k akt
- single cell
- randomized controlled trial
- endothelial cells
- ischemia reperfusion injury
- cell therapy
- endoplasmic reticulum stress
- diabetic rats
- epithelial mesenchymal transition
- systematic review
- anti inflammatory
- stem cells
- induced pluripotent stem cells
- pluripotent stem cells
- newly diagnosed